TRIMYRISTIN

TRIMYRISTIN is a lipid of Glycerolipids (GL) class. Trimyristin is associated with abnormalities such as METABOLIC DISTURBANCE, Hypertensive disease, Glucose Intolerance, Obesity and Cardiovascular Diseases. The involved functions are known as Signal, establishment and maintenance of localization, Saturated, Synthesis and Regulation. Trimyristin often locates in Hepatic, Protoplasm, Adipose tissue and Endoplasmic Reticulum. The associated genes with TRIMYRISTIN are chylomicron remnant, Fusion Protein, Alleles, Mutant Proteins and Genome, Human. The related lipids are Fatty Acids, Palmitates, dipalmitin, cholesteryl oleate and Nonesterified Fatty Acids.

Cross Reference

Introduction

To understand associated biological information of TRIMYRISTIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with TRIMYRISTIN?

TRIMYRISTIN is suspected in Fatty Liver, Non-alcoholic fatty liver, METABOLIC DISTURBANCE, Hypertensive disease, Glucose Intolerance, Obesity and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with TRIMYRISTIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with TRIMYRISTIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with TRIMYRISTIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with TRIMYRISTIN?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with TRIMYRISTIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with TRIMYRISTIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with TRIMYRISTIN

Download all related citations
Per page 10 20 50 100 | Total 86
Authors Title Published Journal PubMed Link
Guse C et al. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. 2006 Int J Pharm pmid:16503388
Ribeiro Dos Santos I et al. Microencapsulation of protein particles within lipids using a novel supercritical fluid process. 2002 Int J Pharm pmid:12176227
Even MP et al. Impact of implant composition of twin-screw extruded lipid implants on the release behavior. 2015 Int J Pharm pmid:26188320
Strasdat B and Bunjes H Development of a new approach to investigating the drug transfer from colloidal carrier systems applying lipid nanosuspension-containing alginate microbeads as acceptor. 2015 Int J Pharm pmid:25943880
Illing A and Unruh T Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles. 2004 Int J Pharm pmid:15454303
Noack A et al. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. 2012 Int J Pharm pmid:22197758
Rao MP et al. Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection--preparation, characterisation and in vivo evaluation. 2014 Int J Pharm pmid:25066077
Olbrich C et al. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity. 2002 Int J Pharm pmid:11955810
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
Royter M et al. Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis. 2009 Extremophiles pmid:19579003
Di Sabatino M et al. Spray congealed lipid microparticles with high protein loading: preparation and solid state characterisation. 2012 Eur J Pharm Sci pmid:22465062
Reitz C et al. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties. 2008 Eur J Pharm Sci pmid:18765281
Vogelhuber W et al. Monolithic glyceryl trimyristate matrices for parenteral drug release applications. 2003 Eur J Pharm Biopharm pmid:12551714
Krause J et al. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion. 2009 Eur J Pharm Biopharm pmid:18805483
Jin SE et al. Cellular delivery of cationic lipid nanoparticle-based SMAD3 antisense oligonucleotides for the inhibition of collagen production in keloid fibroblasts. 2012 Eur J Pharm Biopharm pmid:22705642
Göke K and Bunjes H Carrier characteristics influence the kinetics of passive drug loading into lipid nanoemulsions. 2018 Eur J Pharm Biopharm pmid:28807819
Göke K and Bunjes H Parameters influencing the course of passive drug loading into lipid nanoemulsions. 2018 Eur J Pharm Biopharm pmid:28529070
Petersen S et al. The physical state of lipid nanoparticles influences their effect on in vitro cell viability. 2011 Eur J Pharm Biopharm pmid:21458564
Jaiswal P et al. Enzyme Inhibition by Molluscicidal Components of Myristica fragrans Houtt. in the Nervous Tissue of Snail Lymnaea acuminata. 2010 Enzyme Res pmid:21048864
Suzuki H and Harada M [Identification of nutmeg by thin-layer chromatography and its introduction to Japanese standards for non-pharmacopoeial crude drugs]. 1990 Eisei Shikenjo Hokoku pmid:1364369